No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ADTX Aditxt
- 1.4400
- -0.1200-7.69%
Close Jun 18 16:00 ET
- 1.4692
- +0.0292+2.03%
Post 18:57 ET
2.87MMarket Cap-22P/E (TTM)
1.5600High1.4400Low64.80KVolume1.5600Open1.5600Pre Close95.25KTurnover3.57%Turnover RatioLossP/E (Static)1.99MShares68.080052wk High0.29P/B2.61MFloat Cap1.440052wk Low--Dividend TTM1.81MShs Float19160.0000Historical High--Div YieldTTM7.69%Amplitude1.4400Historical Low1.4690Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Aditxt Inc - as a Result of Company's Failure to Repay Balance on Maturity Date, Company Is in Default on Upsize Note
Express News | Aditxt Inc - IF Co Is Unable to Resolve Default, It May Have an Adverse Effect on Co's Liquidity, Financial Condition and Results of Operations
Express News | Aditxt Inc - Is in Discussions With Sixth Borough to Come to an Amicable Resolution
Express News | Aditxt Inc - Company Is in Default on Upsize Note and Unpaid Principal and Interest Thereon Is Due and Payable
Express News | Evofem Biosciences Announces Issuance Of US Patent No. 11,992,472 Covering Composition And Methods For Contraception With Phexxi Vaginal Gel
Evofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter
Evofem Biosciences, Inc. (OTCQB: EVFM) today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No....
Comments
$Aditxt(ADTX.US$ Aditxt Inc - Company Is in Default on Upsize Note and Unpaid Principal and Interest Thereon Is Due and Payable! Oh no! If not able to work out a deal to square this up? It could mean very bad things for the company!
2
Keep an eye on these M&As: 👀
Onconova Tx merger w/ Trawsfynydd Tx
$Aditxt(ADTX.US$ to acquire Appili Tx
TuHURA Biosciences merger w/ $Kintara Therapeutics(KTRA.US$
$Johnson & Johnson(JNJ.US$ to acquire $ShockWave Medical(SWAV.US$
$Vertex Pharmaceuticals(VRTX.US$ to acquire $Alpine Immune(ALPN.US$
$Century Therapeutics(IPSC.US$ to acquire Clade Tx
$Eliem Therapeutics(ELYM.US$ to acquire Tenet Med.
$Incyte(INCY.US$ to acquire Escient Pharm.
ONO Pharm to acquire $Deciphera Pharmaceuticals(DCPH.US$
...
Onconova Tx merger w/ Trawsfynydd Tx
$Aditxt(ADTX.US$ to acquire Appili Tx
TuHURA Biosciences merger w/ $Kintara Therapeutics(KTRA.US$
$Johnson & Johnson(JNJ.US$ to acquire $ShockWave Medical(SWAV.US$
$Vertex Pharmaceuticals(VRTX.US$ to acquire $Alpine Immune(ALPN.US$
$Century Therapeutics(IPSC.US$ to acquire Clade Tx
$Eliem Therapeutics(ELYM.US$ to acquire Tenet Med.
$Incyte(INCY.US$ to acquire Escient Pharm.
ONO Pharm to acquire $Deciphera Pharmaceuticals(DCPH.US$
...
7
$Aditxt(ADTX.US$
NEWS
Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules
NEWS
Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules
1
$Aditxt(ADTX.US$ to acquire Appili Tx
TuHURA Biosciences merger w/ $Kintara Therapeutics(KTRA.US$
$Johnson & Johnson(JNJ.US$ to acquire $ShockWave Medical(SWAV.US$
$Vertex Pharmaceuticals(VRTX.US$ to acquire $Alpine Immune(ALPN.US$
What companies will be next? 🤔
TuHURA Biosciences merger w/ $Kintara Therapeutics(KTRA.US$
$Johnson & Johnson(JNJ.US$ to acquire $ShockWave Medical(SWAV.US$
$Vertex Pharmaceuticals(VRTX.US$ to acquire $Alpine Immune(ALPN.US$
What companies will be next? 🤔
5
Consolidating back at the 3.00 support. If that holds watch for a curl back up. Here are the levels for next week.
Get the indicator: FrogOracle Trading
Larger Image: tradingview.com...
$Aditxt(ADTX.US$
Get the indicator: FrogOracle Trading
Larger Image: tradingview.com...
$Aditxt(ADTX.US$
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Jaguar8 : Ouch
TrytosaveabitOP Jaguar8: Yup! Could spell a CH 11 if that can’t come to some sort of remedy?